Fig. 2From: Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studiesRisk of heart failure in patients who received GLP-1 agonists versus control from randomized controlled trialsBack to article page